nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenoldopam—Electrocardiogram T wave inversion—Formoterol—chronic obstructive pulmonary disease	0.0414	0.0602	CcSEcCtD
Fenoldopam—Electrocardiogram T wave inversion—Arformoterol—chronic obstructive pulmonary disease	0.0414	0.0602	CcSEcCtD
Fenoldopam—Extrasystoles—Aminophylline—chronic obstructive pulmonary disease	0.013	0.0189	CcSEcCtD
Fenoldopam—Extrasystoles—Arformoterol—chronic obstructive pulmonary disease	0.00988	0.0144	CcSEcCtD
Fenoldopam—Extrasystoles—Formoterol—chronic obstructive pulmonary disease	0.00988	0.0144	CcSEcCtD
Fenoldopam—Myocardial ischaemia—Salbutamol—chronic obstructive pulmonary disease	0.00977	0.0142	CcSEcCtD
Fenoldopam—Extrasystoles—Salbutamol—chronic obstructive pulmonary disease	0.00933	0.0136	CcSEcCtD
Fenoldopam—Urinary tract infection—Roflumilast—chronic obstructive pulmonary disease	0.00891	0.0129	CcSEcCtD
Fenoldopam—Leukocytosis—Formoterol—chronic obstructive pulmonary disease	0.00885	0.0128	CcSEcCtD
Fenoldopam—Leukocytosis—Arformoterol—chronic obstructive pulmonary disease	0.00885	0.0128	CcSEcCtD
Fenoldopam—Hypokalaemia—Aminophylline—chronic obstructive pulmonary disease	0.00722	0.0105	CcSEcCtD
Fenoldopam—Tension—Roflumilast—chronic obstructive pulmonary disease	0.00703	0.0102	CcSEcCtD
Fenoldopam—Nervousness—Roflumilast—chronic obstructive pulmonary disease	0.00696	0.0101	CcSEcCtD
Fenoldopam—Back pain—Roflumilast—chronic obstructive pulmonary disease	0.00693	0.0101	CcSEcCtD
Fenoldopam—Muscle spasms—Roflumilast—chronic obstructive pulmonary disease	0.00689	0.01	CcSEcCtD
Fenoldopam—Nasal congestion—Formoterol—chronic obstructive pulmonary disease	0.00663	0.00962	CcSEcCtD
Fenoldopam—Nasal congestion—Arformoterol—chronic obstructive pulmonary disease	0.00663	0.00962	CcSEcCtD
Fenoldopam—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.00633	0.00919	CcSEcCtD
Fenoldopam—Angina pectoris—Tiotropium—chronic obstructive pulmonary disease	0.0063	0.00914	CcSEcCtD
Fenoldopam—Nasal congestion—Salbutamol—chronic obstructive pulmonary disease	0.00626	0.00909	CcSEcCtD
Fenoldopam—Anxiety—Roflumilast—chronic obstructive pulmonary disease	0.00608	0.00882	CcSEcCtD
Fenoldopam—Urinary tract infection—Tiotropium—chronic obstructive pulmonary disease	0.0056	0.00814	CcSEcCtD
Fenoldopam—Hypokalaemia—Formoterol—chronic obstructive pulmonary disease	0.00549	0.00798	CcSEcCtD
Fenoldopam—Hypokalaemia—Arformoterol—chronic obstructive pulmonary disease	0.00549	0.00798	CcSEcCtD
Fenoldopam—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.00529	0.00768	CcSEcCtD
Fenoldopam—Hypokalaemia—Salbutamol—chronic obstructive pulmonary disease	0.00519	0.00753	CcSEcCtD
Fenoldopam—Flushing—Aminophylline—chronic obstructive pulmonary disease	0.00509	0.00739	CcSEcCtD
Fenoldopam—Angina pectoris—Arformoterol—chronic obstructive pulmonary disease	0.00508	0.00738	CcSEcCtD
Fenoldopam—Angina pectoris—Formoterol—chronic obstructive pulmonary disease	0.00508	0.00738	CcSEcCtD
Fenoldopam—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.005	0.00726	CcSEcCtD
Fenoldopam—Angina pectoris—Salbutamol—chronic obstructive pulmonary disease	0.0048	0.00697	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00478	0.00694	CcSEcCtD
Fenoldopam—Tension—Aminophylline—chronic obstructive pulmonary disease	0.00469	0.00681	CcSEcCtD
Fenoldopam—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.00464	0.00674	CcSEcCtD
Fenoldopam—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00462	0.00671	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Formoterol—chronic obstructive pulmonary disease	0.00459	0.00666	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Arformoterol—chronic obstructive pulmonary disease	0.00459	0.00666	CcSEcCtD
Fenoldopam—Myocardial infarction—Formoterol—chronic obstructive pulmonary disease	0.00456	0.00662	CcSEcCtD
Fenoldopam—Myocardial infarction—Arformoterol—chronic obstructive pulmonary disease	0.00456	0.00662	CcSEcCtD
Fenoldopam—Urinary tract infection—Arformoterol—chronic obstructive pulmonary disease	0.00452	0.00657	CcSEcCtD
Fenoldopam—Urinary tract infection—Formoterol—chronic obstructive pulmonary disease	0.00452	0.00657	CcSEcCtD
Fenoldopam—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.00436	0.00633	CcSEcCtD
Fenoldopam—Urinary tract infection—Salbutamol—chronic obstructive pulmonary disease	0.00427	0.0062	CcSEcCtD
Fenoldopam—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.00422	0.00613	CcSEcCtD
Fenoldopam—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.00421	0.00611	CcSEcCtD
Fenoldopam—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.00405	0.00588	CcSEcCtD
Fenoldopam—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.004	0.00581	CcSEcCtD
Fenoldopam—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.00398	0.00578	CcSEcCtD
Fenoldopam—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.00396	0.00576	CcSEcCtD
Fenoldopam—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.00394	0.00573	CcSEcCtD
Fenoldopam—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00387	0.00561	CcSEcCtD
Fenoldopam—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.00383	0.00557	CcSEcCtD
Fenoldopam—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.0038	0.00552	CcSEcCtD
Fenoldopam—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00372	0.0054	CcSEcCtD
Fenoldopam—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00366	0.00532	CcSEcCtD
Fenoldopam—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.00366	0.00531	CcSEcCtD
Fenoldopam—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00364	0.00529	CcSEcCtD
Fenoldopam—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00359	0.00521	CcSEcCtD
Fenoldopam—Tension—Formoterol—chronic obstructive pulmonary disease	0.00357	0.00518	CcSEcCtD
Fenoldopam—Tension—Arformoterol—chronic obstructive pulmonary disease	0.00357	0.00518	CcSEcCtD
Fenoldopam—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.00353	0.00513	CcSEcCtD
Fenoldopam—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.00353	0.00513	CcSEcCtD
Fenoldopam—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00353	0.00512	CcSEcCtD
Fenoldopam—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.00352	0.00511	CcSEcCtD
Fenoldopam—Back pain—Formoterol—chronic obstructive pulmonary disease	0.00352	0.00511	CcSEcCtD
Fenoldopam—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.00349	0.00508	CcSEcCtD
Fenoldopam—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.00349	0.00508	CcSEcCtD
Fenoldopam—Leukocytosis—Prednisone—chronic obstructive pulmonary disease	0.00348	0.00506	CcSEcCtD
Fenoldopam—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00347	0.00504	CcSEcCtD
Fenoldopam—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.00342	0.00497	CcSEcCtD
Fenoldopam—Tension—Salbutamol—chronic obstructive pulmonary disease	0.00337	0.00489	CcSEcCtD
Fenoldopam—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.00333	0.00484	CcSEcCtD
Fenoldopam—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00332	0.00483	CcSEcCtD
Fenoldopam—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.00332	0.00482	CcSEcCtD
Fenoldopam—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.0033	0.00479	CcSEcCtD
Fenoldopam—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.00321	0.00467	CcSEcCtD
Fenoldopam—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.00321	0.00467	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00319	0.00463	CcSEcCtD
Fenoldopam—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00315	0.00457	CcSEcCtD
Fenoldopam—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00314	0.00457	CcSEcCtD
Fenoldopam—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00309	0.00449	CcSEcCtD
Fenoldopam—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00309	0.00449	CcSEcCtD
Fenoldopam—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00308	0.00448	CcSEcCtD
Fenoldopam—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00308	0.00448	CcSEcCtD
Fenoldopam—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00308	0.00448	CcSEcCtD
Fenoldopam—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00308	0.00448	CcSEcCtD
Fenoldopam—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00303	0.0044	CcSEcCtD
Fenoldopam—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00302	0.00439	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00301	0.00437	CcSEcCtD
Fenoldopam—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00292	0.00424	CcSEcCtD
Fenoldopam—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00291	0.00423	CcSEcCtD
Fenoldopam—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00291	0.00422	CcSEcCtD
Fenoldopam—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.0029	0.0042	CcSEcCtD
Fenoldopam—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.0029	0.0042	CcSEcCtD
Fenoldopam—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00277	0.00403	CcSEcCtD
Fenoldopam—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00277	0.00403	CcSEcCtD
Fenoldopam—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00273	0.00397	CcSEcCtD
Fenoldopam—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00271	0.00393	CcSEcCtD
Fenoldopam—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00268	0.0039	CcSEcCtD
Fenoldopam—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00268	0.0039	CcSEcCtD
Fenoldopam—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00267	0.00387	CcSEcCtD
Fenoldopam—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00264	0.00384	CcSEcCtD
Fenoldopam—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00264	0.00384	CcSEcCtD
Fenoldopam—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00263	0.00382	CcSEcCtD
Fenoldopam—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00262	0.0038	CcSEcCtD
Fenoldopam—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00258	0.00374	CcSEcCtD
Fenoldopam—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00254	0.00368	CcSEcCtD
Fenoldopam—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00254	0.00368	CcSEcCtD
Fenoldopam—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00253	0.00368	CcSEcCtD
Fenoldopam—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.0025	0.00363	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.00248	0.00361	CcSEcCtD
Fenoldopam—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00248	0.0036	CcSEcCtD
Fenoldopam—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.00247	0.00359	CcSEcCtD
Fenoldopam—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00244	0.00355	CcSEcCtD
Fenoldopam—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.00243	0.00353	CcSEcCtD
Fenoldopam—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00243	0.00353	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00243	0.00352	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00243	0.00352	CcSEcCtD
Fenoldopam—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.0024	0.00348	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00238	0.00345	CcSEcCtD
Fenoldopam—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00235	0.00341	CcSEcCtD
Fenoldopam—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00235	0.00341	CcSEcCtD
Fenoldopam—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00235	0.00341	CcSEcCtD
Fenoldopam—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00235	0.00341	CcSEcCtD
Fenoldopam—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00234	0.00339	CcSEcCtD
Fenoldopam—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00232	0.00336	CcSEcCtD
Fenoldopam—Headache—Tiotropium—chronic obstructive pulmonary disease	0.0023	0.00334	CcSEcCtD
Fenoldopam—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.0023	0.00334	CcSEcCtD
Fenoldopam—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.0023	0.00334	CcSEcCtD
Fenoldopam—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.0023	0.00334	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00229	0.00333	CcSEcCtD
Fenoldopam—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.00227	0.0033	CcSEcCtD
Fenoldopam—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.00226	0.00328	CcSEcCtD
Fenoldopam—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00221	0.00322	CcSEcCtD
Fenoldopam—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00221	0.00322	CcSEcCtD
Fenoldopam—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00218	0.00317	CcSEcCtD
Fenoldopam—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.00216	0.00314	CcSEcCtD
Fenoldopam—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00203	0.00295	CcSEcCtD
Fenoldopam—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00203	0.00295	CcSEcCtD
Fenoldopam—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00199	0.00289	CcSEcCtD
Fenoldopam—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00196	0.00285	CcSEcCtD
Fenoldopam—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00196	0.00285	CcSEcCtD
Fenoldopam—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00192	0.00279	CcSEcCtD
Fenoldopam—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00192	0.00278	CcSEcCtD
Fenoldopam—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00189	0.00274	CcSEcCtD
Fenoldopam—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00189	0.00274	CcSEcCtD
Fenoldopam—Headache—Formoterol—chronic obstructive pulmonary disease	0.00186	0.0027	CcSEcCtD
Fenoldopam—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00186	0.0027	CcSEcCtD
Fenoldopam—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00185	0.00269	CcSEcCtD
Fenoldopam—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00185	0.00268	CcSEcCtD
Fenoldopam—Headache—Montelukast—chronic obstructive pulmonary disease	0.00182	0.00264	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.0018	0.00262	CcSEcCtD
Fenoldopam—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.00179	0.00261	CcSEcCtD
Fenoldopam—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00178	0.00259	CcSEcCtD
Fenoldopam—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00176	0.00256	CcSEcCtD
Fenoldopam—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00176	0.00256	CcSEcCtD
Fenoldopam—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00175	0.00255	CcSEcCtD
Fenoldopam—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00173	0.00251	CcSEcCtD
Fenoldopam—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.00167	0.00243	CcSEcCtD
Fenoldopam—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00166	0.00242	CcSEcCtD
Fenoldopam—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.00165	0.0024	CcSEcCtD
Fenoldopam—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.00164	0.00239	CcSEcCtD
Fenoldopam—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.00157	0.00228	CcSEcCtD
Fenoldopam—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.00155	0.00226	CcSEcCtD
Fenoldopam—Flushing—Prednisone—chronic obstructive pulmonary disease	0.00153	0.00221	CcSEcCtD
Fenoldopam—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.00145	0.00211	CcSEcCtD
Fenoldopam—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.00121	0.00176	CcSEcCtD
Fenoldopam—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.00114	0.00165	CcSEcCtD
Fenoldopam—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.00113	0.00164	CcSEcCtD
Fenoldopam—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00106	0.00154	CcSEcCtD
Fenoldopam—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.00106	0.00153	CcSEcCtD
Fenoldopam—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00101	0.00146	CcSEcCtD
Fenoldopam—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000998	0.00145	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000955	0.00139	CcSEcCtD
Fenoldopam—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000954	0.00139	CcSEcCtD
Fenoldopam—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000923	0.00134	CcSEcCtD
Fenoldopam—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000923	0.00134	CcSEcCtD
Fenoldopam—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000799	0.00116	CcSEcCtD
Fenoldopam—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000772	0.00112	CcSEcCtD
Fenoldopam—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000742	0.00108	CcSEcCtD
Fenoldopam—Headache—Prednisone—chronic obstructive pulmonary disease	0.000731	0.00106	CcSEcCtD
Fenoldopam—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000693	0.00101	CcSEcCtD
Fenoldopam—DRD5—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000147	0.000473	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.000147	0.000471	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000147	0.000471	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000146	0.00047	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000145	0.000467	CbGpPWpGaD
Fenoldopam—ADRA2C—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.000145	0.000467	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000144	0.000463	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000144	0.000463	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000144	0.000462	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000142	0.000456	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000142	0.000456	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000142	0.000456	CbGpPWpGaD
Fenoldopam—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	0.000141	0.000454	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000141	0.000453	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000139	0.000446	CbGpPWpGaD
Fenoldopam—DRD2—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	0.000138	0.000442	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000137	0.00044	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000137	0.00044	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000137	0.000439	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000135	0.000435	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000135	0.000433	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000134	0.00043	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000134	0.00043	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000133	0.000427	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000132	0.000423	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000132	0.000423	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000131	0.00042	CbGpPWpGaD
Fenoldopam—DRD2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000131	0.00042	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.00013	0.000417	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000128	0.000412	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000128	0.000411	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000127	0.000407	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000126	0.000405	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000126	0.000405	CbGpPWpGaD
Fenoldopam—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	0.000126	0.000403	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000125	0.000402	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000125	0.000401	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000124	0.0004	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000124	0.000399	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.000124	0.000397	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—ALB—chronic obstructive pulmonary disease	0.000123	0.000396	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000122	0.000393	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000122	0.000391	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000121	0.000387	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.00012	0.000385	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.00012	0.000384	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.00012	0.000384	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000119	0.000382	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.000118	0.000379	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000118	0.000378	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000118	0.000378	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000117	0.000376	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000117	0.000376	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000116	0.000373	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000115	0.00037	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000113	0.000363	CbGpPWpGaD
Fenoldopam—ADRA2B—Hemostasis—VEGFA—chronic obstructive pulmonary disease	0.000112	0.00036	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000111	0.000357	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—CTGF—chronic obstructive pulmonary disease	0.00011	0.000353	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000109	0.000349	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000109	0.000349	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000107	0.000345	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000107	0.000344	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000105	0.000339	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000105	0.000337	CbGpPWpGaD
Fenoldopam—ADRA2C—Hemostasis—VEGFA—chronic obstructive pulmonary disease	0.000105	0.000336	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000105	0.000336	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000104	0.000334	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000104	0.000333	CbGpPWpGaD
Fenoldopam—ADRA2B—Hemostasis—TGFB1—chronic obstructive pulmonary disease	0.000103	0.00033	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000103	0.000329	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000101	0.000325	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—KL—chronic obstructive pulmonary disease	9.81e-05	0.000315	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	9.79e-05	0.000314	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.78e-05	0.000314	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	9.73e-05	0.000312	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	9.72e-05	0.000312	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.69e-05	0.000311	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	9.66e-05	0.00031	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—KL—chronic obstructive pulmonary disease	9.65e-05	0.00031	CbGpPWpGaD
Fenoldopam—ADRA2C—Hemostasis—TGFB1—chronic obstructive pulmonary disease	9.61e-05	0.000309	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	9.59e-05	0.000308	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	9.57e-05	0.000307	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.56e-05	0.000307	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.33e-05	0.0003	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	9.22e-05	0.000296	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.06e-05	0.000291	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.05e-05	0.000291	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.91e-05	0.000286	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	8.91e-05	0.000286	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—KL—chronic obstructive pulmonary disease	8.9e-05	0.000286	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.89e-05	0.000286	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.83e-05	0.000284	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.77e-05	0.000282	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.72e-05	0.00028	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.72e-05	0.00028	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.66e-05	0.000278	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	8.57e-05	0.000275	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	8.57e-05	0.000275	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—VEGFA—chronic obstructive pulmonary disease	8.5e-05	0.000273	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.5e-05	0.000273	CbGpPWpGaD
Fenoldopam—ADRA2B—Hemostasis—TP53—chronic obstructive pulmonary disease	8.47e-05	0.000272	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.45e-05	0.000271	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.39e-05	0.000269	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.33e-05	0.000268	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	8.21e-05	0.000264	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.15e-05	0.000262	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.09e-05	0.00026	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.02e-05	0.000257	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	7.96e-05	0.000256	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.96e-05	0.000256	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.92e-05	0.000254	CbGpPWpGaD
Fenoldopam—ADRA2C—Hemostasis—TP53—chronic obstructive pulmonary disease	7.91e-05	0.000254	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	7.91e-05	0.000254	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.91e-05	0.000254	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.9e-05	0.000254	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.87e-05	0.000253	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	7.81e-05	0.000251	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.8e-05	0.00025	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.76e-05	0.000249	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.57e-05	0.000243	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.52e-05	0.000241	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.4e-05	0.000238	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.39e-05	0.000237	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.36e-05	0.000236	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.35e-05	0.000236	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	7.35e-05	0.000236	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.34e-05	0.000236	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.28e-05	0.000234	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.23e-05	0.000232	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.15e-05	0.00023	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.12e-05	0.000229	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.07e-05	0.000227	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.07e-05	0.000227	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.04e-05	0.000226	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.96e-05	0.000224	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.71e-05	0.000216	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.67e-05	0.000214	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	6.62e-05	0.000212	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.58e-05	0.000211	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	6.57e-05	0.000211	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.5e-05	0.000209	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.47e-05	0.000208	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.47e-05	0.000208	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—TP53—chronic obstructive pulmonary disease	6.43e-05	0.000206	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.43e-05	0.000206	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.42e-05	0.000206	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.42e-05	0.000206	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.41e-05	0.000206	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.2e-05	0.000199	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.18e-05	0.000199	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—ALB—chronic obstructive pulmonary disease	6.16e-05	0.000198	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.12e-05	0.000197	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.01e-05	0.000193	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.97e-05	0.000192	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.97e-05	0.000192	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.92e-05	0.00019	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.89e-05	0.000189	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—NOS3—chronic obstructive pulmonary disease	5.89e-05	0.000189	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.84e-05	0.000188	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.79e-05	0.000186	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.78e-05	0.000186	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.75e-05	0.000185	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.75e-05	0.000185	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.53e-05	0.000177	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.41e-05	0.000174	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.34e-05	0.000172	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.32e-05	0.000171	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.27e-05	0.000169	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.25e-05	0.000169	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.18e-05	0.000166	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.16e-05	0.000166	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.08e-05	0.000163	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—ALB—chronic obstructive pulmonary disease	5e-05	0.000161	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.99e-05	0.00016	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.93e-05	0.000158	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.93e-05	0.000158	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.91e-05	0.000158	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.85e-05	0.000156	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.85e-05	0.000156	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—NOS3—chronic obstructive pulmonary disease	4.79e-05	0.000154	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.75e-05	0.000153	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.73e-05	0.000152	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.69e-05	0.000151	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.68e-05	0.00015	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.68e-05	0.00015	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.51e-05	0.000145	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.47e-05	0.000144	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.45e-05	0.000143	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.44e-05	0.000143	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.39e-05	0.000141	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.37e-05	0.00014	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.31e-05	0.000138	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.3e-05	0.000138	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.27e-05	0.000137	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.23e-05	0.000136	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.21e-05	0.000135	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.19e-05	0.000135	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.16e-05	0.000133	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.09e-05	0.000131	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4e-05	0.000129	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.97e-05	0.000127	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.95e-05	0.000127	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.92e-05	0.000126	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.89e-05	0.000125	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.86e-05	0.000124	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.84e-05	0.000123	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.82e-05	0.000123	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.8e-05	0.000122	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.79e-05	0.000122	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.77e-05	0.000121	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.63e-05	0.000117	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.59e-05	0.000115	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.55e-05	0.000114	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.55e-05	0.000114	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.49e-05	0.000112	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.49e-05	0.000112	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.46e-05	0.000111	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.42e-05	0.00011	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.38e-05	0.000108	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.26e-05	0.000105	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.22e-05	0.000104	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.22e-05	0.000103	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.21e-05	0.000103	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.21e-05	0.000103	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.19e-05	0.000103	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.18e-05	0.000102	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.14e-05	0.000101	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.1e-05	9.96e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.96e-05	9.49e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.95e-05	9.47e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.91e-05	9.35e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.9e-05	9.31e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.88e-05	9.26e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.87e-05	9.22e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.85e-05	9.15e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.79e-05	8.97e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.68e-05	8.61e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.65e-05	8.5e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.64e-05	8.48e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.63e-05	8.44e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.59e-05	8.33e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.46e-05	7.88e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.43e-05	7.81e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.42e-05	7.76e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.34e-05	7.53e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.23e-05	7.15e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.18e-05	7e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.15e-05	6.89e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.99e-05	6.4e-05	CbGpPWpGaD
